Profile data is unavailable for this security.
About the company
BICO Group AB, previously Cellink AB is a Sweden-based company, which is primarily involved in the healthcare industry. The Company focuses on the application areas of bioprinting, multiomics, cell line development, and diagnostics. The Company develops and markets technologies that enable researchers in the life sciences to culture cells in 3D, perform high-throughput drug screening and print human tissues and organs for the medical, pharmaceutical, and cosmetic industries. The Company’s operations divided in two segments: The Industrial Solutions segment that offers products within precision dispensing and biosensor technology for industrial customers, which make a high-capacity contribution to customers production; and The Laboratory Solutions segment that offers 3Dprinters, single- cell and liquid- dispensing instruments as well as services and consumables related to these products.
- Revenue in SEK (TTM)1.51bn
- Net income in SEK-1.26bn
- Incorporated2016
- Employees586.00
- LocationBICO Group ABLangfilsgatan 9GOETEBORG 412 77SwedenSWE
- Phone+46 20101000
- Websitehttps://bico.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| OssDsign AB | 180.16m | -50.99m | 661.54m | 32.00 | -- | 2.13 | -- | 3.67 | -0.5493 | -0.5493 | 2.06 | 2.80 | 0.5109 | 0.3672 | 6.95 | 5,629,938.00 | -14.46 | -25.42 | -16.05 | -28.59 | 96.29 | 85.57 | -28.30 | -82.42 | 6.33 | -13.77 | 0.0044 | -- | 34.51 | 48.59 | -2.68 | -- | 24.28 | -- |
| BioPorto A/S | 51.70m | -122.74m | 691.05m | 48.00 | -- | 12.76 | -- | 13.37 | -0.1973 | -0.1973 | 0.083 | 0.0774 | 0.4132 | 2.55 | 4.69 | 962,131.60 | -98.08 | -65.22 | -133.92 | -88.74 | 63.90 | 64.15 | -237.40 | -222.22 | 1.71 | -- | 0.1916 | -- | 17.07 | 6.36 | -21.15 | -- | -20.56 | -- |
| Senzime AB (publ) | 89.71m | -120.62m | 696.46m | 50.00 | -- | 2.00 | -- | 7.76 | -0.8672 | -0.8672 | 0.6394 | 2.22 | 0.234 | 1.73 | 5.99 | 1,794,120.00 | -31.47 | -35.09 | -34.04 | -37.52 | 41.86 | 8.75 | -134.46 | -400.65 | 4.30 | -7.70 | 0.0399 | -- | 63.55 | 54.18 | 11.50 | -- | 40.12 | -- |
| Gentian Diagnostics ASA | 161.91m | 40.15m | 781.59m | 63.00 | 19.75 | 4.12 | 16.07 | 4.83 | 2.73 | 2.73 | 11.07 | 13.10 | 0.8181 | 1.63 | 7.83 | 2,738,365.00 | 20.29 | -2.99 | 22.99 | -3.36 | 55.06 | 44.66 | 24.80 | -5.84 | 4.16 | -- | 0.0094 | -- | 12.52 | 25.96 | 525.37 | -- | 22.08 | -- |
| Omda AS | 445.71m | -28.41m | 824.02m | 260.00 | -- | 25.79 | 29.62 | 1.85 | -1.51 | -1.51 | 23.59 | 1.63 | 0.6793 | 26.59 | 21.70 | 1,772,075.00 | -4.33 | -5.14 | -5.39 | -6.63 | 93.69 | 91.09 | -6.37 | -10.32 | 0.6483 | 0.5281 | 0.9359 | -- | 3.45 | 15.80 | -163.95 | -- | -15.57 | -- |
| Nexstim Oyj | 106.34m | -2.99m | 895.48m | 40.00 | -- | 26.55 | 127.69 | 8.42 | -0.042 | -0.042 | 1.47 | 0.4426 | 0.8553 | 0.5613 | 4.66 | 251,616.80 | -2.40 | -12.40 | -4.17 | -20.76 | 94.36 | 95.09 | -2.81 | -16.29 | 1.08 | 0.7835 | 0.6002 | -- | 20.55 | 21.14 | 32.79 | -- | 15.13 | -- |
| Sedana Medical AB (publ) | 197.61m | -40.65m | 949.66m | 117.00 | -- | 1.05 | -- | 4.81 | -0.4092 | -0.4092 | 1.99 | 9.14 | 0.2012 | 1.46 | 9.47 | 2,670,406.00 | -4.14 | -4.90 | -4.34 | -5.16 | 70.47 | 68.32 | -20.57 | -30.26 | 3.28 | -21.90 | 0.0045 | -- | 16.17 | 20.06 | 82.09 | -- | 26.45 | -- |
| C Rad AB | 457.70m | 23.25m | 1.04bn | 107.00 | 45.51 | 2.99 | 30.52 | 2.26 | 0.6922 | 0.6922 | 13.58 | 10.53 | -- | -- | -- | 4,623,273.00 | -- | 8.44 | -- | 11.73 | 51.45 | 45.00 | 5.08 | 8.28 | 2.98 | 3.31 | 0.0252 | 0.00 | 10.45 | 17.96 | 58.88 | -- | -9.15 | -- |
| ADDvise Group AB (publ) | 1.62bn | 4.30m | 1.04bn | 615.00 | 19.91 | 0.9402 | 9.37 | 0.6416 | 0.0864 | 0.0864 | 3.44 | 1.83 | 0.5167 | 7.91 | 4.96 | 2,534,790.00 | 0.1399 | 3.41 | 0.174 | 4.28 | 39.91 | 46.52 | 0.2708 | 6.06 | 0.7562 | 1.62 | 0.5251 | 0.4389 | 21.68 | 36.71 | -13.04 | 85.85 | 52.63 | -- |
| Paxman AB (publ) | 295.08m | 4.92m | 1.14bn | 142.00 | 177.39 | 2.66 | 46.18 | 3.86 | 0.2757 | 0.2757 | 14.26 | 18.38 | 0.8486 | 3.45 | 4.71 | 2,810,305.00 | 1.37 | 0.8426 | 1.60 | 1.20 | 67.34 | 68.75 | 1.61 | 0.7966 | 4.07 | 1.71 | 0.0245 | 0.00 | 20.41 | 24.30 | 382.55 | 70.92 | -3.73 | -- |
| BICO Group AB | 1.51bn | -1.26bn | 1.16bn | 586.00 | -- | 0.6564 | -- | 0.7727 | -17.83 | -9.68 | 21.34 | 25.67 | 0.3269 | 3.30 | 3.65 | 2,074,793.00 | -27.41 | -- | -35.79 | -- | 36.91 | -- | -83.83 | -- | 1.13 | -- | 0.4174 | -- | -3.19 | -- | 88.56 | -- | -- | -- |
| Surgical Science Sweden AB | 975.04m | 69.83m | 1.22bn | 328.00 | 17.48 | 0.2839 | 8.38 | 1.25 | 1.37 | 1.37 | 19.11 | 84.27 | 0.2051 | 1.72 | 7.09 | 3,558,537.00 | 1.47 | 3.91 | 1.55 | 4.18 | 66.61 | 68.94 | 7.16 | 21.55 | 3.44 | -- | 0.0004 | 0.00 | 0.1398 | 54.17 | -43.73 | 59.89 | 39.76 | -- |
| Genovis AB | 116.63m | 21.19m | 1.30bn | 36.00 | 61.15 | 4.94 | 40.43 | 11.17 | 0.3225 | 0.3225 | 1.78 | 3.99 | 0.3404 | -- | -- | 3,644,719.00 | 6.18 | 15.62 | 6.57 | 17.56 | 90.28 | 88.86 | 18.16 | 25.11 | -- | -- | 0.2171 | 0.00 | -17.62 | 16.58 | -46.48 | 28.08 | -1.42 | -- |
| Stille AB | 552.55m | 40.41m | 1.33bn | 208.00 | 33.00 | 1.93 | 15.05 | 2.41 | 4.50 | 4.50 | 62.09 | 77.10 | 0.531 | 1.55 | 7.66 | 3,891,176.00 | 3.88 | 6.20 | 4.55 | 7.11 | 52.45 | 47.21 | 7.31 | 9.48 | 1.87 | -- | 0.00 | 16.29 | 93.27 | 29.47 | 118.44 | 20.53 | 13.88 | -- |
| Nordhealth As | 531.22m | -112.58m | 1.40bn | 450.00 | -- | 3.55 | -- | 2.63 | -1.52 | -1.52 | 7.16 | 9.29 | 0.6188 | -- | 8.10 | 1,377,212.00 | -13.11 | -- | -14.99 | -- | 82.95 | -- | -21.19 | -- | -- | -- | 0.00 | -- | 24.03 | -- | 31.06 | -- | -- | -- |
| Carasent AB (publ) | 328.93m | -18.60m | 1.66bn | 196.00 | -- | 1.95 | 37.64 | 5.06 | -0.268 | -0.268 | 4.64 | 11.78 | 0.3226 | -- | 7.35 | 1,652,936.00 | -1.82 | -- | -2.04 | -- | 84.59 | -- | -5.65 | -- | -- | -- | 0.0412 | -- | 12.27 | -- | 9.46 | -- | -- | -- |
Data as of Feb 12 2026. Currency figures normalised to BICO Group AB's reporting currency: Swedish Krona SEK
17.46%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Fj�rde AP-fondenas of 30 Jun 2025 | 4.44m | 6.42% |
| Handelsbanken Fonder ABas of 28 Nov 2025 | 3.71m | 5.37% |
| ARK Investment Management LLCas of 09 Jan 2026 | 1.20m | 1.74% |
| Wahlstedt & Partners ABas of 31 Dec 2025 | 622.03k | 0.90% |
| Norges Bank Investment Managementas of 30 Jun 2025 | 501.85k | 0.73% |
| SEB Funds ABas of 31 Dec 2025 | 478.84k | 0.69% |
| Lannebo Kapitalf�rvaltning AB (Sweden)as of 31 Dec 2025 | 458.57k | 0.66% |
| Mandarine Gestion SAas of 30 Jun 2025 | 260.00k | 0.38% |
| Storebrand Asset Management ASas of 30 Nov 2025 | 225.62k | 0.33% |
| SSgA Funds Management, Inc.as of 08 Jan 2026 | 168.85k | 0.24% |
More ▼
Data from 30 Jun 2025 - 31 Dec 2025Source: FactSet Research Systems Inc.
